Management of Macular Hemorrhage in Diabetic Patients

Immediate Referral and Treatment Criteria

The American Diabetes Association recommends prompt referral to an ophthalmologist for patients with macular hemorrhage, particularly those with diabetic retinopathy, macular edema, severe nonproliferative diabetic retinopathy (NPDR), or proliferative diabetic retinopathy (PDR), as these patients require urgent assessment to prevent permanent vision loss 1, 2, 3
Patients with macular hemorrhage may be asymptomatic despite sight-threatening disease, and delayed treatment significantly worsens outcomes, emphasizing the need for immediate referral 1, 5

Intravitreal anti-VEGF injections (ranibizumab 0.3 mg or aflibercept) are the primary treatment for diabetic macular edema with hemorrhage, administered monthly initially, with treatment continuation until stabilization, then adjusted based on disease activity 2, 6
Anti-VEGF therapy improves diabetic retinopathy severity scores by 2 or more steps in 29-37% of patients compared to 8-16% with laser alone, highlighting its efficacy in treating diabetic macular edema 6
Laser photocoagulation remains indicated for high-risk proliferative diabetic retinopathy and clinically significant macular edema, though anti-VEGF therapy is now considered non-inferior or superior 1, 2, 3

Hypertension significantly increases the risk of macular hemorrhage and must be aggressively controlled, with target blood pressure optimized before and during treatment 5, 1
Intensive glycemic control (targeting near-normoglycemia) prevents and delays diabetic retinopathy progression, reducing hemorrhage risk, and hemoglobin A1c should be assessed and optimized as part of treatment planning 1, 2, 5, 7

Aspirin therapy for cardioprotection should not be discontinued, as it does not increase the risk of retinal hemorrhage in diabetic retinopathy patients 1, 2, 4

Patients require frequent monitoring after macular hemorrhage, as sight-threatening events can occur within days to weeks even after apparent stabilization, with monthly follow-up recommended initially, and frequency adjusted based on disease activity 2, 6

Pregnant diabetic patients require intensified monitoring, as pregnancy accelerates diabetic retinopathy progression, with eye examination in the first trimester and close follow-up throughout pregnancy and for 1 year postpartum 1, 2, 3, 5